The annual flu reimbursement letter was updated on 1 April. A copy of the latest version can be found online. The letter confirmed that those aged 50-64 year old will be included in the 21/22 flu programme. The letter also confirmed the inclusion of a QIVr vaccine (Supemtek).
Community pharmacies and General Practice should ensure that they order enough vaccine to achieve or exceed the same level of uptake as the 2020/21 season. They may wish to consider ordering additional vaccine if required to support the vaccination of the 50-64 year old cohort. Community pharmacy are expected to play a strong role in vaccinating the 50 to 64 year old cohorts to ensure the availability of general practice capacity to continue their focus on flu and COVID-19 vaccination of the most vulnerable clinical cohorts.